TPST
Tempest Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.27
-0.04 (-3.05%)
Rating:D+
Company Profile
CEO
Matthew Angel
IPO Date
2012-11-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.28
Prev. Close
$1.31
Day Low
$1.24
Day High
$1.29
52W Low
$1.24
52W High
$12.23
Market Cap
$0.01B
Volume
0.12M